Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Correction

Correction to: Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer

Authors: Jessica A. Gibbons, Jagat R. Kanwar, Rupinder K. Kanwar

Published in: BMC Cancer | Issue 1/2018

Login to get access

Excerpt

It has been highlighted that the original article [1] contains an error in Fig. 3 specifically, that it showed an incorrect version of Fig. 3c. This does not affect the Figure legend, results and conclusions of the article. The correct version of Fig. 3 is shown in this Correction article.
Metadata
Title
Correction to: Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer
Authors
Jessica A. Gibbons
Jagat R. Kanwar
Rupinder K. Kanwar
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4658-1

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine